USPTO backs WARF stem cell patents


Eileen McDermott, New York and Eklavya Gupte, London 

The Wisconsin Alumni Research Foundation (WARF) was celebrating last month after the USPTO issued favourable decisions on three controversial patent applications for stem cells. But two public interest groups who challenged the patents have vowed to fight the latest rulings.

Last month, the PTO approved amended applications for two of the patents (numbers 5,843,780 and 6,200,806), which claim preparations of, respectively, primate and human embryonic stem cells and methods for their isolation. In a separate decision, on February 23, a third patent (number 7,029,913) was upheld by the PTO following an obviousness challenge.

The technology in all three patents was developed by the scientist who established the...



Only subscribers have complete access to Managing IP Magazine, log in or subscribe now.

Alternatively take a free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).

Subscribe Now

This article is available to subscribers. Please click subscribe to read the rest of the article.

Subscribe

Take a free trial

Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.

Take a free trial


More from the Managing IP blog


June 2013

The Madrid Protocol comes of age

India’s accession means the Madrid Protocol now covers more than two-thirds of the world’s population. Is this the tipping-point for the international trade mark system, and what reforms are needed? Emma Barraclough, James Nurton and Alli Pyrah report



Most read articles

Poll

Following the US Apple v Samsung trial, do you think juries should play a role in patent cases?







Supplements